Logo-jrip
Submitted: 11 Oct 2020
Accepted: 20 Jan 2020
ePublished: 14 Feb 2020
EndNote EndNote

(Enw Format - Win & Mac)

BibTeX BibTeX

(Bib Format - Win & Mac)

Bookends Bookends

(Ris Format - Mac only)

EasyBib EasyBib

(Ris Format - Win & Mac)

Medlars Medlars

(Txt Format - Win & Mac)

Mendeley Web Mendeley Web
Mendeley Mendeley

(Ris Format - Win & Mac)

Papers Papers

(Ris Format - Win & Mac)

ProCite ProCite

(Ris Format - Win & Mac)

Reference Manager Reference Manager

(Ris Format - Win only)

Refworks Refworks

(Refworks Format - Win & Mac)

Zotero Zotero

(Ris Format - Firefox Plugin)

J Renal Inj Prev. 2020;9(2): e11.
doi: 10.34172/jrip.2020.11

Scopus ID: 85084456964
  Abstract View: 2717
  PDF Download: 1227

Original

The effect of a care plan based on the Roy adaptation model on general health in hemodialysis patients; a randomized controlled clinical trial

Monir Nobahar 1,2,3 ORCID logo, Mohadese Saffari 4 ORCID logo, Hassan Babamohamadi 1,2* ORCID logo, Nemat Sotodehasl 1,2 ORCID logo, Majid Mirmohammadkhani 3,5 ORCID logo

1 Nursing Care Research Centre, Semnan University of Medical Sciences, Semnan, Iran
2 Department of Nursing, Faculty of Nursing and Midwifery, Semnan University of Medical Sciences, Semnan, Iran
3 Social Determinants of Health Research Centre, Semnan University of Medical Sciences, Semnan, Iran
4 Student Research Committee, Semnan University of Medical Sciences, Semnan, Iran
5 Department of Epidemiology and Statistics, Faculty of Medicine, Semnan University of Medical Sciences, Semnan, Iran
*Corresponding Author: *Corresponding author: Hassan Babamohamadi, Email: babamohamadi@semums.ac.ir, , Email: babamohammady2007@gmail.com

Abstract

Introduction: Evidence suggests that end-stage renal disease (ESRD) significantly affects general health in the patients, causing their general health to be poorer compared to the general population. The Roy adaptation model (RAM) is the best one for ESRD patients.

Objectives: The present study aimed to determine the effect of a RAM-based care plan on general health in hemodialysis patients.

Patients and Methods: This randomized controlled clinical trial conducted on 60 hemodialysis patients in Iran. The data collected using a demographic questionnaire and the general health questionnaire-28 (GHQ-28). In the intervention group, the Roy assessment form was completed and the RAM-based care plan was then trained in four group sessions over 4 weeks. Individual sessions were also held if required and patients followed-up for 2 weeks. The control group received only routine care. At the end of the follow-up, general health was re-assessed in the patients. The findings were analysed using t test, the chi-square test and the McNemar test.

Results: Despite observing no significant differences between the two groups in terms of general health levels before the intervention (P=0.530), the difference was significant after the intervention (P=0.028), since the mean score of general health decreased by 4.07 in the intervention group compared to before the intervention (P=0.003). The intervention significantly affected the subscales of somatic symptoms (P=0.013), anxiety and insomnia (P=0.006), social dysfunction (P=0.016) and depression (P=0.031).

Conclusion: The findings suggested the positive effects of using the RAM on general health in hemodialysis patients. The RAM is therefore recommended that be used as a holistic care approach to improving general health in these patients.


Implication for health policy/practice/research/medical education:

The findings of present study suggested the positive effects of using the Roy adaptation model (RAM) on general health in hemodialysis patients. Given the chronic trend of hemodialysis, the RAM is recommended that be consistently utilized for promoting general health in hemodialysis patients.

Please cite this paper as: Nobahar M, Saffari M, Babamohamadi H, Sotodehasl N, Mirmohammadkhani M. The effect of a care plan based on the Roy adaptation model on general health in hemodialysis patients; a randomized controlled clinical trial. J Renal Inj Prev. 2020; 9(2): e11. doi: 10.34172/jrip.2020.11.

First Name
 
Last Name
 
Email Address
 
Comments
 
Security code


Abstract View: 2718

Your browser does not support the canvas element.


PDF Download: 1227

Your browser does not support the canvas element.